GW&K Investment Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31K | Hold |
442
| – | – | ﹤0.01% | 599 |
|
|
2025
Q1 | $31K | Sell |
442
-239
| -35% | -$16.8K | ﹤0.01% | 560 |
|
|
2024
Q4 | $59K | Buy |
681
+250
| +58% | +$21.7K | ﹤0.01% | 451 |
|
|
2024
Q3 | $51K | Hold |
431
| – | – | ﹤0.01% | 466 |
|
|
2024
Q2 | $62K | Sell |
431
-6
| -1% | -$863 | ﹤0.01% | 424 |
|
|
2024
Q1 | $56K | Buy |
437
+111
| +34% | +$14.2K | ﹤0.01% | 416 |
|
|
2023
Q4 | $34K | Hold |
326
| – | – | ﹤0.01% | 443 |
|
|
2023
Q3 | $30K | Sell |
326
-50
| -13% | -$4.6K | ﹤0.01% | 443 |
|
|
2023
Q2 | $30K | Buy |
376
+326
| +652% | +$26K | ﹤0.01% | 431 |
|
|
2023
Q1 | $4K | Hold |
50
| – | – | ﹤0.01% | 425 |
|
|
2022
Q4 | $3K | Sell |
50
-44
| -47% | -$2.64K | ﹤0.01% | 399 |
|
|
2022
Q3 | $5K | Hold |
94
| – | – | ﹤0.01% | 382 |
|
|
2022
Q2 | $5K | Hold |
94
| – | – | ﹤0.01% | 607 |
|
|
2022
Q1 | $5K | Sell |
94
-23,716
| -100% | -$1.26M | ﹤0.01% | 551 |
|
|
2021
Q4 | $1.33M | Sell |
23,810
-11,492
| -33% | -$643K | 0.01% | 318 |
|
|
2021
Q3 | $1.7M | Buy |
35,302
+468
| +1% | +$22.5K | 0.02% | 319 |
|
|
2021
Q2 | $1.46M | Buy |
34,834
+1,854
| +6% | +$77.7K | 0.01% | 325 |
|
|
2021
Q1 | $1.11M | Buy |
32,980
+4,802
| +17% | +$162K | 0.01% | 329 |
|
|
2020
Q4 | $984K | Buy |
28,178
+2,474
| +10% | +$86.4K | 0.01% | 327 |
|
|
2020
Q3 | $892K | Buy |
25,704
+706
| +3% | +$24.5K | 0.01% | 288 |
|
|
2020
Q2 | $818K | Buy |
24,998
+2,210
| +10% | +$72.3K | 0.01% | 285 |
|
|
2020
Q1 | $686K | Buy |
22,788
+12,712
| +126% | +$383K | 0.01% | 276 |
|
|
2019
Q4 | $292K | Buy |
10,076
+2,678
| +36% | +$77.6K | ﹤0.01% | 317 |
|
|
2019
Q3 | $191K | Buy |
+7,398
| New | +$191K | ﹤0.01% | 326 |
|